跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ELOCTATE efmoroctocog alfa (rhu) 2000 IU powder for injection vial and diluent pre-filled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
ELOCTATE efmoroctocog alfa (rhu) 2000 IU powder for injection vial and diluent pre-filled syringe
Approved
STANDARD
ELOCTATE efmoroctocog alfa (rhu) 2000 IU powder for injection vial and diluent pre-filled syringe
Sanofi-Aventis Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
6365a14599e88226
Company
Sanofi-Aventis Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
6365a14599e88226
Product Name
ELOCTATE efmoroctocog alfa (rhu) 2000 IU powder for injection vial and diluent pre-filled syringe
Artg Id
210524
Artg Name
ELOCTATE efmoroctocog alfa (rhu) 2000 IU powder for injection vial and diluent pre-filled syringe
Sponsor
Sanofi-Aventis Australia Pty Ltd
Company Detail Path
/organization/sanofi-aventis-australia-pty-ltd
Artg Date
2014-06-27
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/94fc5f93a7fccaf064951154a8b92a50.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/efce60d6ee9660856ac614b4051d1f2f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
6365a14599e88226
Type
Standard
Back to TGA Approvals